CIK 0001651308
- Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981209416
- Phone
- +41 616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 4 Open-market sale Director sold 7,000 shares at an average $212.92 ($1,490,460)
- 4 Open-market sale Director sold 4,000 shares at an average $211.06 ($844,229)
- 4 Open-market sale Chief Executive Officer sold 17,254 shares at an average $223.27 ($3,852,273)
- 4 Open-market sale Chief Executive Officer sold 40,559 shares at an average $221.27 ($8,974,526)
- 4 Open-market sale CMO, Hematology sold 3,000 shares at an average $209.93 ($629,787)
- 4 Open-market sale Chief Executive Officer sold 27,748 shares at an average $238.34 ($6,613,503)
- 4 Open-market sale Chief Executive Officer sold 55,175 shares at an average $251.84 ($13,895,479)
- 4 Open-market sale Director sold 17,000 shares at an average $251.51 ($4,275,636)
- 4 Open-market sale President & GM China sold 3,300 shares at an average $249.22 ($822,422)
- 4 Grant or award Director acquired 14,584,180 shares (grant or award)
- 4 Grant or award 10% owner acquired 29,614,832 shares (grant or award)
- 4 Open-market sale President & GM China sold 5,700 shares at an average $230.00 ($1,310,998)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 6,000 shares at $200.00 ($1,200,000)
- 4 Open-market sale CMO, Hematology sold 3,921 shares at $200.00 ($784,200)
- 4 Open-market sale Chief Executive Officer sold 53,914 shares at an average $199.12 ($10,735,455)
- 4 Open-market sale Director sold 4,847 shares at an average $190.75 ($924,572)
- 4 Open-market sale Chief Executive Officer sold 5,251 shares at an average $191.85 ($1,007,391)
- 4 Open-market sale CFO & Chief Strategy Officer sold 300 shares at $191.23 ($57,368)
- 4 Open-market sale CMO, Hematology sold 4,014 shares at an average $195.73 ($785,647)
Page 19 of 29 · 580 filings